13.07.2015 Views

Bavarian Biotech Report 2011/2012 (7MB) - Bio M

Bavarian Biotech Report 2011/2012 (7MB) - Bio M

Bavarian Biotech Report 2011/2012 (7MB) - Bio M

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

conoGenetix biosciences GmbHBIOTECH THERAPEUTICS & DIAGNOSTICSContact:Dr. Andreas KlostermannAm Klopferspitz 19D-82152 MartinsriedPhone: +49 (0) 89 5472-6950Fax: +49 (0) 89 5472-6959E-Mail: info@conogenetix.deInternet: www.conogenetix.deKeywords: Cardiovascular Diseases, Pain, CNS, Peptide/Protein, DrugDevelopmentconoGenetix is a privately owned biopharmaceutical company focused onthe development of new peptide therapeutics for the treatment of autoimmunediseases. conoGenetix was founded in 2002 by Dr. AndreasKlostermann and Dr. Jörg Stockhaus and is located in Martinsried,Germany. The company has developed an integrated technology platformthat allows for the efficient discovery of drug leads that modulate ion channeltargets causatively involved in the generation of autoimmune diseases.conoGenetix runs a program targeting severe autoimmune disorders likeMultiple Sclerosis (MS), Rheumatoid Arthritis (RA) and Vasculitis. Severalpeptides called cgtx-peptides within this program are in preclinical development.The leading indication for the cgtx-peptides will be Vasculitis; a fataldisease strongly related to Rheumatoid Arthritis. Vasculitis is a rare diseaseand will be a market door opener for conoGenetix.Contact:Jürgen SchäferNeuhauser Str. 47D-80331 MünchenPhone: +49 (0) 89 236650-0Fax: +49 (0) 89 236650-50E-Mail: schaefer@conreso.comInternet: www.conreso.comConreso GmbHCROKeywords: Clinical Research, Logistics, Monitoring, Drug DevelopmentConreso, established in 1990, BVMA member, offers a wide range of clinicalresearch services. Conreso shows an impressive record of successful FDAinspections and significant contributions to important new product licensesin Europe and the USA. Having recruited more than 30,000 patients between0 and 17 years of age proves the company’s unique expertise in pediatrictrials. The Hannover Clinical Trial Center, a joint venture of Conreso andthe Medizinische Hochschule Hannover, provides Conreso‘s clients access tothe clinical expertise and the comprehensive diagnostic and therapeuticfacilities of one of the leading academic medical institutions in Germany.The Conreso Institute of Veterinary medicine provides all types of veterinarystudies.50

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!